Octreotide Market Size, Forecast, and Developments Through 2032
03. Mai 2024 05:46 ET
|
Research and Markets
Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The "Octreotide Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. The report provides an...
Somatostatin Analogs Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 - Opportunities in the Acromegaly and Neuroendocrine Tumor Markets
16. Februar 2024 05:18 ET
|
Research and Markets
Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "Somatostatin Analogs Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The...
Global Somatostatin Analogs Market to Reach $8.67 Billion by 2028 - Forecast Shows Rapid Growth in Asia-Pacific and Innovation Trends
25. Januar 2024 05:42 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Somatostatin Analogs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global market for somatostatin...
Somatostatin Analogs Market revenue to reach USD 10 Billion by 2035, says Research Nester
16. Oktober 2023 05:30 ET
|
Research Nester
New York, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The global somatostatin analogs market size is slated to expand at ~6% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 10...
Somatostatin Analogs Market revenue to reach USD 10 Billion by 2035, says Research Nester
03. Oktober 2023 07:00 ET
|
Research Nester
New York, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The global somatostatin analogs market size is predicted to expand at ~ 6% CAGR between 2023 and 2035. The market is projected to garner a revenue of USD...
Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment
09. Januar 2023 08:30 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Global Somatostatin Analogs Market Intelligence Report to 2027 - Featuring CVS Health, Ipsen Pharma and Pfizer Among Others
25. Juli 2022 06:43 ET
|
Research and Markets
Dublin, July 25, 2022 (GLOBE NEWSWIRE) -- The "Somatostatin Analogs Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global...
Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference
23. September 2021 16:05 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Rani Therapeutics (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the oral delivery of biologics, today announced that the...
Rani Therapeutics Reports Second Quarter 2021 Financial Results, Provides Corporate Update
13. September 2021 16:05 ET
|
Rani Therapeutics, LLC
- IPO in July 2021 raised $84.3 million in gross proceeds -- Talat Imran Appointed Chief Executive Officer -- Enhanced leadership team with key management and board of directors’ appointments - SAN...
Rani Therapeutics Announces Appointment of Eric Groen as General Counsel
09. September 2021 08:00 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on advancing...